Annual Current Liabilities
$5.94 M
+$1.61 M+37.13%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual total current liabilities is $5.94 million, with the most recent change of +$1.61 million (+37.13%) on April 30, 2024.
- During the last 3 years, IPA annual current liabilities has risen by +$998.10 thousand (+20.18%).
- IPA annual current liabilities is now -17.22% below its all-time high of $7.18 million, reached on April 30, 2022.
Performance
IPA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$8.92 M
+$855.00 K+10.60%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly total current liabilities is $8.92 million, with the most recent change of +$855.00 thousand (+10.60%) on October 31, 2024.
- Over the past year, IPA quarterly current liabilities has increased by +$855.00 thousand (+10.60%).
- IPA quarterly current liabilities is now at all-time high.
Performance
IPA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
IPA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.1% | +10.6% |
| 3 y3 years | +20.2% | +10.6% |
| 5 y5 years | +11.0% | +10.6% |
IPA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.2% | +37.1% | at high | +116.0% |
| 5 y | 5-year | -17.2% | +37.1% | at high | +116.0% |
| alltime | all time | -17.2% | >+9999.0% | at high | >+9999.0% |
ImmunoPrecise Antibodies Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $8.92 M(+10.6%) |
| Jul 2024 | - | $8.07 M(+35.7%) |
| Apr 2024 | $5.94 M(+37.1%) | $5.94 M(-12.3%) |
| Jan 2024 | - | $6.78 M(+24.4%) |
| Oct 2023 | - | $5.45 M(+12.5%) |
| Jul 2023 | - | $4.84 M(+11.7%) |
| Apr 2023 | $4.33 M(-39.6%) | $4.33 M(-12.8%) |
| Jan 2023 | - | $4.97 M(-7.4%) |
| Oct 2022 | - | $5.37 M(+30.0%) |
| Jul 2022 | - | $4.13 M(-42.5%) |
| Apr 2022 | $7.18 M(+45.2%) | $7.18 M(+28.3%) |
| Jan 2022 | - | $5.60 M(-7.8%) |
| Oct 2021 | - | $6.07 M(+14.5%) |
| Jul 2021 | - | $5.30 M(+7.2%) |
| Apr 2021 | $4.95 M(-12.7%) | $4.95 M(-12.6%) |
| Jan 2021 | - | $5.66 M(-3.9%) |
| Oct 2020 | - | $5.89 M(+3.9%) |
| Jul 2020 | - | $5.66 M(-0.0%) |
| Apr 2020 | $5.67 M(+5.8%) | $5.67 M(+16.0%) |
| Jan 2020 | - | $4.88 M(-8.3%) |
| Oct 2019 | - | $5.33 M(-6.0%) |
| Jul 2019 | - | $5.67 M(+5.9%) |
| Apr 2019 | $5.35 M(+60.5%) | $5.35 M(+168.2%) |
| Jan 2019 | - | $2.00 M(-29.8%) |
| Oct 2018 | - | $2.84 M(-9.1%) |
| Jul 2018 | - | $3.13 M(-6.3%) |
| Apr 2018 | $3.34 M(+443.3%) | $3.34 M(+166.4%) |
| Jan 2018 | - | $1.25 M(+214.2%) |
| Oct 2017 | - | $398.50 K(-8.1%) |
| Jul 2017 | - | $433.80 K(-29.3%) |
| Apr 2017 | $613.90 K(+233.1%) | $613.90 K(+30.4%) |
| Jan 2017 | - | $470.70 K(+156.4%) |
| Sep 2016 | - | $183.60 K(-1.5%) |
| Jun 2016 | - | $186.40 K(-6.8%) |
| Mar 2016 | - | $199.90 K(+8.5%) |
| Dec 2015 | $184.30 K(-16.0%) | - |
| Dec 2015 | - | $184.30 K(+3.2%) |
| Sep 2015 | - | $178.50 K(-7.5%) |
| Jun 2015 | - | $192.90 K(-5.9%) |
| Mar 2015 | - | $205.00 K(-6.6%) |
| Dec 2014 | $219.40 K(-23.0%) | - |
| Dec 2014 | - | $219.40 K(-8.0%) |
| Sep 2014 | - | $238.50 K(-11.8%) |
| Jun 2014 | - | $270.30 K(+4.0%) |
| Mar 2014 | - | $260.00 K(-8.8%) |
| Dec 2013 | $285.00 K(+6.7%) | - |
| Dec 2013 | - | $285.00 K(+2.6%) |
| Sep 2013 | - | $277.90 K(+1.1%) |
| Jun 2013 | - | $274.80 K(+3.6%) |
| Mar 2013 | - | $265.30 K(-0.6%) |
| Dec 2012 | $267.00 K(+27.9%) | - |
| Dec 2012 | - | $267.00 K(+10.7%) |
| Sep 2012 | - | $241.30 K(+9.3%) |
| Jun 2012 | - | $220.70 K(-5.3%) |
| Mar 2012 | - | $233.10 K(+11.7%) |
| Dec 2011 | $208.70 K(+89.4%) | - |
| Dec 2011 | - | $208.70 K(+17.5%) |
| Sep 2011 | - | $177.60 K(+39.3%) |
| Jun 2011 | - | $127.50 K(+45.4%) |
| Mar 2011 | - | $87.70 K(-20.4%) |
| Dec 2010 | $110.20 K | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | $110.20 K(-38.4%) |
| Sep 2010 | - | $178.80 K(+75.6%) |
| Jun 2010 | - | $101.80 K(+2.9%) |
| Mar 2010 | - | $98.90 K(+6.5%) |
| Dec 2009 | $92.90 K(-24.1%) | - |
| Dec 2009 | - | $92.90 K(+72.4%) |
| Sep 2009 | - | $53.90 K(+11.4%) |
| Jun 2009 | - | $48.40 K(-18.5%) |
| Mar 2009 | - | $59.40 K(-51.5%) |
| Dec 2008 | $122.40 K(+226.4%) | - |
| Dec 2008 | - | $122.40 K(-65.4%) |
| Sep 2008 | - | $353.30 K(+369.8%) |
| Jun 2008 | - | $75.20 K(+158.4%) |
| Mar 2008 | - | $29.10 K(-22.4%) |
| Dec 2007 | $37.50 K(-89.4%) | - |
| Dec 2007 | - | $37.50 K(+30.2%) |
| Sep 2007 | - | $28.80 K(-50.6%) |
| Jun 2007 | - | $58.30 K(-56.8%) |
| Mar 2007 | - | $135.00 K(-61.9%) |
| Dec 2006 | $354.70 K(+197.3%) | - |
| Dec 2006 | - | $354.70 K(-29.0%) |
| Sep 2006 | - | $499.90 K(+1003.5%) |
| Jun 2006 | - | $45.30 K(+6.3%) |
| Mar 2006 | - | $42.60 K(-64.3%) |
| Dec 2005 | $119.30 K(+203.6%) | - |
| Dec 2005 | - | $119.30 K(-79.0%) |
| Sep 2005 | - | $568.90 K(+84.5%) |
| Jun 2005 | - | $308.30 K(+978.0%) |
| Mar 2005 | - | $28.60 K(-27.2%) |
| Dec 2004 | $39.30 K(+2.3%) | - |
| Dec 2004 | - | $39.30 K(-59.4%) |
| Sep 2004 | - | $96.80 K(+11.8%) |
| Jun 2004 | - | $86.60 K(+274.9%) |
| Mar 2004 | - | $23.10 K(-39.8%) |
| Dec 2003 | $38.40 K(+105.3%) | - |
| Dec 2003 | - | $38.40 K(-61.5%) |
| Sep 2003 | - | $99.80 K(+309.0%) |
| Jun 2003 | - | $24.40 K(+123.9%) |
| Mar 2003 | - | $10.90 K(-41.7%) |
| Dec 2002 | $18.70 K(-84.1%) | - |
| Dec 2002 | - | $18.70 K(+57.1%) |
| Sep 2002 | - | $11.90 K(-42.5%) |
| Jun 2002 | - | $20.70 K(-86.8%) |
| Mar 2002 | - | $156.60 K(+33.3%) |
| Dec 2001 | $117.50 K(-80.3%) | - |
| Dec 2001 | - | $117.50 K(-0.5%) |
| Sep 2001 | - | $118.10 K(-17.2%) |
| Jun 2001 | - | $142.60 K(-72.5%) |
| Mar 2001 | - | $518.50 K(-13.2%) |
| Dec 2000 | $597.50 K(+8435.7%) | - |
| Dec 2000 | - | $597.50 K(+446.2%) |
| Sep 2000 | - | $109.40 K(+145.3%) |
| Jun 2000 | - | $44.60 K(+309.2%) |
| Mar 2000 | - | $10.90 K(+55.7%) |
| Dec 1999 | $7000.00(-69.7%) | - |
| Dec 1999 | - | $7000.00(-69.7%) |
| Dec 1998 | $23.10 K(-50.5%) | - |
| Dec 1998 | - | $23.10 K(-50.5%) |
| Dec 1997 | $46.70 K(-74.4%) | - |
| Dec 1997 | - | $46.70 K |
| Dec 1996 | $182.50 K | - |
FAQ
- What is ImmunoPrecise Antibodies annual total current liabilities?
- What is the all time high annual current liabilities for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual current liabilities year-on-year change?
- What is ImmunoPrecise Antibodies quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly current liabilities year-on-year change?
What is ImmunoPrecise Antibodies annual total current liabilities?
The current annual current liabilities of IPA is $5.94 M
What is the all time high annual current liabilities for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual total current liabilities is $7.18 M
What is ImmunoPrecise Antibodies annual current liabilities year-on-year change?
Over the past year, IPA annual total current liabilities has changed by +$1.61 M (+37.13%)
What is ImmunoPrecise Antibodies quarterly total current liabilities?
The current quarterly current liabilities of IPA is $8.92 M
What is the all time high quarterly current liabilities for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly total current liabilities is $8.92 M
What is ImmunoPrecise Antibodies quarterly current liabilities year-on-year change?
Over the past year, IPA quarterly total current liabilities has changed by +$855.00 K (+10.60%)